[¿Óóµ¥Àϸ®]±¹¸³¾Ï¼¾ÅÍ(¿øÀå ÀÌÀº¼÷)´Â Áö³ 6¿ù 22ÀÏ(±Ý) ¼¿ï·Ôµ¥È£ÅÚ¿¡¼ °³ÃÖµÈ ¡®Á¦44Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× ±¹Á¦¾ÏÄÁÆÛ·±½º¡¯¿¡¼ ÃÑ 5°³ÀÇ Çмú»óÀ» µ¿½Ã ¼ö»óÇß´Ù.
ÀÌÀº¼÷ ¿øÀå ¹× °ø¼±¿µ ´ë¿ÜÇù·Â½ÇÀå/Áø´Ü°Ë»çÀÇÇаúÀåÀº ¡®Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients¡¯·Î, ¿ø¿µÁÖ Á߾Ӿϵî·Ï»ç¾÷ºÎÀåÀº ¡®Lung Cancer Epidemiology in Korea¡¯·Î, ¹ÚÀÎÇý ¾ÏÁß°³¿¬±¸°úÀåÀº ¡®An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer¡¯ ³í¹®À¸·Î °¢°¢ ·Î½´ ¾ÏÇмú»óÀ» ¼ö»óÇß´Ù.
|